Valuation: 10x Genomics, Inc.

Market Cap 8.43B 7.24B 6.79B 6.2B 11.71B 804B 11.77B 80.39B 31.16B 406B 31.66B 30.97B 1,344B P/E 2026 *
-87x
P/E 2027 * -90.2x
Enterprise Value 7.95B 6.82B 6.4B 5.85B 11.04B 758B 11.09B 75.78B 29.37B 382B 29.84B 29.2B 1,267B EV / Sales 2026 *
12.8x
EV / Sales 2027 * 11.6x
Free-Float
90.79%
Yield 2026 *
-
Yield 2027 * -
1 day-0.47%
1 week+3.04%
Current month+35.56%
1 month+39.55%
3 months+160.28%
6 months+189.56%
Current year+292.89%
1 week 60.69
Extreme 60.6945
66.94
1 month 44.39
Extreme 44.39
66.94
Current year 15.9
Extreme 15.9
66.94
1 year 11.16
Extreme 11.16
66.94
3 years 6.78
Extreme 6.78
66.94
5 years 6.78
Extreme 6.78
191.15
10 years 6.78
Extreme 6.78
208.99
Manager TitleAgeSince
Chief Executive Officer 49 2012-07-01
President 51 2012-09-30
Director of Finance/CFO 51 2024-08-11
Director TitleAgeSince
Director/Board Member 51 2012-07-01
Director/Board Member 49 2012-07-01
Chairman 68 2013-07-31
Date Insider Type Main position Quantity % Market Cap.
8/20/26 Don

Founder

-4,000 0.0034%
8/14/26 Sell

Director

-2,273 0.0019%
8/11/26 Sell

Chairman

-20,000 0.0171%
Change 5-day change 1-year change 3-year change Capi.($)
-0.64%+3.04%+356.74%+35.65% 8.43B
+4.46%+5.41%+171.43%+350.47% 22.13B
-1.59%+1.64%-37.77%-22.73% 10.37B
-4.91%+17.46%-30.36% - 7.92B
+0.07%+0.50%+81.43%+52.09% 6.58B
-0.12%-3.82%-14.67%-10.78% 6.01B
-0.39%+2.88%-16.36%-20.14% 4.39B
-2.48%-11.72%+56.86%+98.49% 4.09B
+0.26%-0.55%-19.52%-24.57% 2.91B
+0.94%+19.51% - - 1.45B
Average -0.42%+6.01%+60.86%+57.31% 7.43B
Weighted average by Cap. +0.41%+6.57%+92.30%+128.52%

Financials

2026 *2027 *
Net sales 620M 532M 499M 456M 861M 59.13B 865M 5.91B 2.29B 29.83B 2.33B 2.28B 98.8B 679M 583M 547M 500M 943M 64.79B 948M 6.48B 2.51B 32.69B 2.55B 2.5B 108B
Net income -97.79M -83.94M -78.78M -71.95M -136M -9.33B -136M -932M -361M -4.71B -367M -359M -15.59B -91.65M -78.66M -73.83M -67.43M -127M -8.74B -128M -874M -339M -4.41B -344M -337M -14.61B
Net Debt -484M -415M -390M -356M -672M -46.15B -675M -4.61B -1.79B -23.28B -1.82B -1.78B -77.12B -539M -463M -434M -397M -749M -51.43B -752M -5.14B -1.99B -25.95B -2.02B -1.98B -85.94B
Logo 10x Genomics, Inc.
10x Genomics, Inc. is a life science technology company. The Company's integrated solutions include instruments, consumables and software for single cell and spatial biology systems. Its single cell portfolio, powered by Chromium platform, includes its Chromium X Series, Chromium Connect and legacy Chromium Controller instruments, microfluidic chips and related consumables, which enables throughput analysis of individual biological components. Its Visium platform enables researchers to understand the spatial positions of biological analytes within tissues at high resolution. Its Xenium platform for in situ analysis is designed to give scientists the ability to not only locate and type cells in their tissue context. Its products include Chromium Single Cell Gene Expression, Chromium Single Cell Gene Expression Flex, Chromium Single Cell Immune Profiling, Chromium Single Cell assay for transposase accessible chromatin (ATAC), Visium Spatial Gene Expression, and others.
Employees
1,178
Date Price Change Volume
26-08-26 US$64.10 -0.96% 1,797,572
26-08-25 US$64.72 +1.44% 4,128,949
26-08-24 US$63.80 -2.03% 3,742,622
26-08-21 US$65.12 +1.96% 3,249,549
26-08-20 US$63.87 +2.70% 3,230,166
Trader
Investor
-
Global
-
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
64.72USD
Average target price
49.54USD
Spread / Average Target
-23.46%

Quarterly revenue - Rate of surprise